Abstract
PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in Greece
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have